Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide
A Hajri, C Bruns, P Marbach, et al.
Life Sciences
|
January 1, 1993
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
R Albert, P Marbach, W Bauer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 1999
Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR
E Comets, F Mentré, F Nimmerfall, et al.
Journal of Clinical Gastroenterology
|
June 1, 1989
Long-acting somatostatin analog controls acid and gastrin secretion in benign, not in malignant, Zollinger-Ellison syndrome
F E Bauer, M Hummel, H S Merki, et al.
Experientia
|
December 15, 1979
Two novel prolactin release-inhibiting 8 alpha-amino-ergolines
E Flückiger, U Briner, H R Bürki, et al.
European Journal of Endocrinology
|
October 7, 2000
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment
A Kaal, H Orskov, S Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1995
Sandostatin LAR in acromegalic patients: a dose-range study
A K Fløgstad, J Halse, T Haldorsen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Sandostatin LAR in acromegalic patients: long-term treatment
A K Fløgstad, J Halse, S Bakke, et al.
Life Sciences
|
September 13, 1982
SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action
W Bauer, U Briner, W Doepfner, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 9, 2010
Sotrastaurin and everolimus pharmacokinetics after single-dose coadministration
J M Kovarik, M Bartlett, C Rordorf, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide
A Hajri, C Bruns, P Marbach, et al.
Life Sciences
|
January 1, 1993
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
R Albert, P Marbach, W Bauer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 20, 1999
Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR
E Comets, F Mentré, F Nimmerfall, et al.
Journal of Clinical Gastroenterology
|
June 1, 1989
Long-acting somatostatin analog controls acid and gastrin secretion in benign, not in malignant, Zollinger-Ellison syndrome
F E Bauer, M Hummel, H S Merki, et al.
Experientia
|
December 15, 1979
Two novel prolactin release-inhibiting 8 alpha-amino-ergolines
E Flückiger, U Briner, H R Bürki, et al.
European Journal of Endocrinology
|
October 7, 2000
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment
A Kaal, H Orskov, S Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1995
Sandostatin LAR in acromegalic patients: a dose-range study
A K Fløgstad, J Halse, T Haldorsen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Sandostatin LAR in acromegalic patients: long-term treatment
A K Fløgstad, J Halse, S Bakke, et al.
Life Sciences
|
September 13, 1982
SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action
W Bauer, U Briner, W Doepfner, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 9, 2010
Sotrastaurin and everolimus pharmacokinetics after single-dose coadministration
J M Kovarik, M Bartlett, C Rordorf, et al.
Page
of 4